Summary:
This research is being conducted on an experimental drug called KYG0395. The purpose of the study is to evaluate the safety and efficacy of KYG0395 in female subjects 18 to 35 years of age with primary dysmenorrhea (menstrual cramps). The study will also evaluate if taking KYG0395 is better than taking a placebo.
Qualified Participants Must:
• Be 18 to 35 years of age
•
Suffer from primary dysmenorrhea which is defined as cramping pain in the lower abdomen and/or pelvis just before or during menstruation